{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:55:01Z","timestamp":1782896101428,"version":"3.54.5"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":105,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Military Infectious Diseases Research Program","award":["A1210"],"award-info":[{"award-number":["A1210"]}]},{"name":"Military Infectious Diseases Research Program","award":["110411"],"award-info":[{"award-number":["110411"]}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["R01 AI161017"],"award-info":[{"award-number":["R01 AI161017"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Humanized (h) DRAGA mice are a promising in vivo model for investigating immunotherapies for treating HIV infections. These mice are not only susceptible to HIV infection, but they also develop functional human immune cells, including T cells and B cells, as well as follicular-like structures that mimic lymphoid B-cell follicles, where HIV-producing cells concentrate during infection in a manner similar to that found in humans. This study evaluated HIV-infected hDRAGA mice as a model for testing the safety, tissue targeting, and efficacy of HIV-specific CAR\/CXCR5 T cells. We also evaluated whether HIV infection in hDRAGA mice can be suppressed by antiretroviral therapy. We produced functional HIV-specific CAR\/CXCR5 T cells from disaggregated hDRAGA splenocytes and infused cell products into HIV-infected hDRAGA mice. CAR\/CXCR5 T cells persisted in hDRAGA mice for the duration of the study, peaking 6 d postinfusion. Treatment with CAR\/CXCR5 T cells appeared to be safe, with 100% survival rate and no noticeable changes in pathology. Six days after infusion, CAR\/CXCR5 T cells had accumulated in the follicle-like structures in the spleen, with many in direct contact with HIV-producing cells. However, CAR\/CXCR5 T-cell treatment did not reduce viral loads compared to controls, likely because CD4 T cells in the infused product became infected with and spread HIV infection. Despite this, all mice treated with antiretroviral therapy showed complete suppression of viral replication, indicating that HIV infection was treatment responsive in the DRAGA mice. These studies indicate that hDRAGA mice are a valuable model to study cellular immunotherapies for HIV.<\/jats:p>","DOI":"10.1093\/jimmun\/vkaf185","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T22:51:11Z","timestamp":1755125471000},"page":"3017-3027","source":"Crossref","is-referenced-by-count":3,"title":["Humanized DRAGA mice are a valuable model to study novel immunotherapies for HIV-1"],"prefix":"10.1093","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9837-8209","authenticated-orcid":false,"given":"Pongthorn","family":"Pumtang-On","sequence":"first","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, University of Minnesota , St Paul, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3867-6448","authenticated-orcid":false,"given":"Liliana K","family":"Thron","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, University of Minnesota , St Paul, MN,","place":["United States"]},{"name":"Graduate Program in Molecular Pharmacology and Therapeutics, University of Minnesota , Minneapolis, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Goodarzi","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, University of Minnesota , St Paul, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna C","family":"Davey","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, University of Minnesota , St Paul, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily N","family":"Sevcik","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, University of Minnesota , St Paul, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Coleman-Fuller","sequence":"additional","affiliation":[{"name":"MarPam Pharma, LLC , St Paul, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad F","family":"Karim","sequence":"additional","affiliation":[{"name":"Agile Vaccines and Therapeutic, Infectious Diseases Directorate, Naval Medical Research Command , Silver Spring, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaiva","family":"Vezys","sequence":"additional","affiliation":[{"name":"Center for Immunology, Department of Microbiology and Immunology, University of Minnesota , Minneapolis, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Rao","sequence":"additional","affiliation":[{"name":"Laboratory of Adjuvant and Antigen Research, United States Military HIV Research Program, Walter Reed Army Institute of Research , Silver Spring, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branden S","family":"Moriarity","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota , Minneapolis, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S","family":"Pampusch","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, University of Minnesota , St Paul, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron K","family":"Rendahl","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, University of Minnesota , St Paul, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia A","family":"Casares","sequence":"additional","affiliation":[{"name":"Agile Vaccines and Therapeutic, Infectious Diseases Directorate, Naval Medical Research Command , Silver Spring, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J","family":"Skinner","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, University of Minnesota , St Paul, MN,","place":["United States"]},{"name":"MarPam Pharma, LLC , St Paul, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"2025112603023534200_vkaf185-B1","volume-title":"HIV statistics, globally and by WHO region, 2024","author":"World Health Organization","year":"2024"},{"key":"2025112603023534200_vkaf185-B2","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.4049\/jimmunol.177.8.5668","article-title":"Human CD4+ T cells lyse target cells via granzyme\/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptor","volume":"177","author":"Hombach","year":"2006","journal-title":"J Immunol"},{"key":"2025112603023534200_vkaf185-B3","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1038\/sigtrans.2016.2","article-title":"Treatment of CD20-directed chimeric antigen receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report","volume":"1","author":"Zhang","year":"2016","journal-title":"Signal Transduct Target Ther"},{"key":"2025112603023534200_vkaf185-B4","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"2025112603023534200_vkaf185-B5","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N Engl J Med"},{"key":"2025112603023534200_vkaf185-B6","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.2147\/OTT.S312904","article-title":"Anti-CD22 CAR-T cell therapy as a salvage treatment in B cell malignancies refractory or relapsed after anti-CD19 CAR-T therapy","volume":"14","author":"Zhu","year":"2021","journal-title":"Onco Targets Ther"},{"key":"2025112603023534200_vkaf185-B7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcyt.2017.11.001","article-title":"Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity","volume":"20","author":"Ghanem","year":"2018","journal-title":"Cytotherapy"},{"key":"2025112603023534200_vkaf185-B8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fimmu.2018.00492","article-title":"Simian immunodeficiency virus (SIV)\u2013specific chimeric antigen receptor-T cells engineered to target B cell follicles and suppress SIV replication","volume":"9","author":"Haran","year":"2018","journal-title":"Front Immunol"},{"key":"2025112603023534200_vkaf185-B9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4049\/immunohorizons.2200073","article-title":"HIV-specific CAR T cells with CD28 or 4-1BB signaling domains are phenotypically and functionally distinct and effective at suppressing HIV and simian immunodeficiency virus","volume":"6","author":"Cartwright","year":"2022","journal-title":"Immunohorizons"},{"key":"2025112603023534200_vkaf185-B10","doi-asserted-by":"crossref","first-page":"e1009831","DOI":"10.1371\/journal.ppat.1009831","article-title":"CAR\/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection","volume":"18","author":"Pampusch","year":"2022","journal-title":"PLoS Pathog"},{"key":"2025112603023534200_vkaf185-B11","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12010155","article-title":"The impact and effects of host immunogenetics on infectious disease studies using non-human primates in biomedical research","volume":"12","author":"Berry","year":"2024","journal-title":"Microorganisms"},{"key":"2025112603023534200_vkaf185-B12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1089\/aid.2017.0173","article-title":"Short communication: comparative susceptibility of rhesus macaques of Indian and Chinese origin to vaginal simian-human immunodeficiency virus transmission as models for HIV prevention research","volume":"33","author":"Veazey","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025112603023534200_vkaf185-B13","doi-asserted-by":"crossref","first-page":"e0109423","DOI":"10.1128\/jvi.01094-23","article-title":"Host immunity associated with spontaneous suppression of viremia in therapy-na\u00efve young rhesus macaques following neonatal SHIV infection","volume":"97","author":"Evangelous","year":"2023","journal-title":"J Virol"},{"key":"2025112603023534200_vkaf185-B14","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1128\/jvi.69.11.7061-7067.1995","article-title":"Persistent infection of macaques with simian-human immunodeficiency viruses","volume":"69","author":"Li","year":"1995","journal-title":"J Virol"},{"key":"2025112603023534200_vkaf185-B15","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1073\/pnas.92.16.7490","article-title":"Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian\/human immunodeficiency viruses (SHIV)","volume":"92","author":"Luciw","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025112603023534200_vkaf185-B16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/viro.1997.8744","article-title":"Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian\/human immunodeficiency viruses in Macaca mulatta","volume":"236","author":"Bogers","year":"1997","journal-title":"Virology"},{"key":"2025112603023534200_vkaf185-B17","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1128\/jvi.70.5.3189-3197.1996","article-title":"Chimeric simian\/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques","volume":"70","author":"Joag","year":"1996","journal-title":"J Virol"},{"key":"2025112603023534200_vkaf185-B18","doi-asserted-by":"crossref","first-page":"e1006753","DOI":"10.1371\/journal.ppat.1006753","article-title":"Long-term persistence and function of hematopoietic stem cell\u2013derived chimeric antigen receptor T cells in a nonhuman primate model of HIV\/AIDS","volume":"13","author":"Zhen","year":"2017","journal-title":"PLoS Pathog"},{"key":"2025112603023534200_vkaf185-B19","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1128\/jvi.70.10.6922-6928.1996","article-title":"A chimeric simian\/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys","volume":"70","author":"Reimann","year":"1996","journal-title":"J Virol"},{"key":"2025112603023534200_vkaf185-B20","doi-asserted-by":"crossref","first-page":"e141502","DOI":"10.1172\/jci.insight.141502","article-title":"Stem cell-derived CAR T cells traffic to HIV reservoirs in macaques","volume":"6","author":"Barber-Axthelm","year":"2021","journal-title":"JCI Insight"},{"key":"2025112603023534200_vkaf185-B21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57646","article-title":"Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation","volume":"10","author":"Cardozo-Ojeda","year":"2021","journal-title":"Elife"},{"key":"2025112603023534200_vkaf185-B22","doi-asserted-by":"crossref","first-page":"e00071-21","DOI":"10.1128\/JVI.00071-21","article-title":"New SHIVs and improved design strategy for modeling HIV-1 transmission, immunopathogenesis, prevention and cure","volume":"95","author":"Li","year":"2021","journal-title":"J Virol"},{"key":"2025112603023534200_vkaf185-B23","doi-asserted-by":"crossref","first-page":"e0165223","DOI":"10.1128\/jvi.01652-23","article-title":"SHIV-C109p5 NHP induces rapid disease progression in elderly macaques with extensive GI viral replication","volume":"98","author":"Bose","year":"2024","journal-title":"J Virol"},{"key":"2025112603023534200_vkaf185-B24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12977-016-0268-7","article-title":"In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection","volume":"13","author":"Tsai","year":"2016","journal-title":"Retrovirology"},{"key":"2025112603023534200_vkaf185-B25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.20062411","article-title":"Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1","volume":"204","author":"Sun","year":"2007","journal-title":"J Exp Med"},{"key":"2025112603023534200_vkaf185-B26","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3389\/fimmu.2017.01405","article-title":"Tracking human immunodeficiency virus-1 infection in the humanized DRAG mouse model","volume":"8","author":"Kim","year":"2017","journal-title":"Front Immunol"},{"key":"2025112603023534200_vkaf185-B27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2015.05.002","article-title":"BLT humanized mice as a small animal model of HIV infection","volume":"13","author":"Karpel","year":"2015","journal-title":"Curr Opin Virol"},{"key":"2025112603023534200_vkaf185-B28","doi-asserted-by":"crossref","first-page":"eaav5685","DOI":"10.1126\/scitranslmed.aav5685","article-title":"Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model","volume":"11","author":"Anthony-Gonda","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025112603023534200_vkaf185-B29","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41591-020-1039-5","article-title":"Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo","volume":"26","author":"Maldini","year":"2020","journal-title":"Nat Med"},{"key":"2025112603023534200_vkaf185-B30","doi-asserted-by":"crossref","first-page":"e1009404","DOI":"10.1371\/journal.ppat.1009404","article-title":"Robust CAR-T memory formation and function via hematopoietic stem cell delivery","volume":"17","author":"Zhen","year":"2021","journal-title":"PLoS Pathog"},{"key":"2025112603023534200_vkaf185-B31","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00705-016-2942-4","article-title":"VRC01 antibody protects against vaginal and rectal transmission of human immunodeficiency virus 1 in hu-BLT mice","volume":"161","author":"Sun","year":"2016","journal-title":"Arch Virol"},{"key":"2025112603023534200_vkaf185-B32","doi-asserted-by":"crossref","first-page":"e00814-19","DOI":"10.1128\/JVI.00814-19","article-title":"Immunization of BLT humanized mice redirects T cell responses to Gag and reduces acute HIV-1 viremia","volume":"93","author":"Claiborne","year":"2019","journal-title":"J Virol"},{"key":"2025112603023534200_vkaf185-B33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41590-019-0416-z","article-title":"Humanized immune system mouse models: progress, challenges and opportunities","volume":"20","author":"Allen","year":"2019","journal-title":"Nat Immunol"},{"key":"2025112603023534200_vkaf185-B34","doi-asserted-by":"crossref","first-page":"e7251","DOI":"10.1371\/journal.pone.0007251","article-title":"Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice","volume":"4","author":"Jaiswal","year":"2009","journal-title":"PLoS One"},{"key":"2025112603023534200_vkaf185-B35","doi-asserted-by":"crossref","first-page":"13022","DOI":"10.1073\/pnas.1000475107","article-title":"Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gamma(null) humanized mice","volume":"107","author":"Shultz","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025112603023534200_vkaf185-B36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jim.2015.02.007","article-title":"Evaluation of the efficiency of human immune system reconstitution in NSG mice and NSG mice containing a human HLA.A2 transgene using hematopoietic stem cells purified from different sources","volume":"422","author":"Patton","year":"2015","journal-title":"J Immunol Methods"},{"key":"2025112603023534200_vkaf185-B37","doi-asserted-by":"crossref","first-page":"28093","DOI":"10.1038\/srep28093","article-title":"Differential effect of HLA class-I versus class-II transgenes on human T and B cell reconstitution and function in NRG mice","volume":"6","author":"Majji","year":"2016","journal-title":"Sci Rep"},{"key":"2025112603023534200_vkaf185-B38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12936-018-2264-y","article-title":"Humanized DRAGA mice immunized with Plasmodium falciparum sporozoites and chloroquine elicit protective pre-erythrocytic immunity","volume":"17","author":"Majji","year":"2018","journal-title":"Malar J"},{"key":"2025112603023534200_vkaf185-B39","doi-asserted-by":"crossref","first-page":"1047277","DOI":"10.3389\/fimmu.2022.1047277","article-title":"HIV-1 infected humanized DRAGA mice develop HIV-specific antibodies despite lack of canonical germinal centers in secondary lymphoid tissues","volume":"13","author":"Ollerton","year":"2022","journal-title":"Front Immunol"},{"key":"2025112603023534200_vkaf185-B40","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1080\/21645515.2020.1713605","article-title":"The humanized DRAGA mouse (HLA-A2. HLA-DR4. RAG1 KO. IL-2R g c KO. NOD) establishes inducible and transmissible models for influenza type A infections","volume":"16","author":"Mendoza","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"2025112603023534200_vkaf185-B41","doi-asserted-by":"crossref","first-page":"2048622","DOI":"10.1080\/21645515.2022.2048622","article-title":"Human-immune-system (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2R\u03b3cKO.NOD) for COVID-19","volume":"18","author":"Brumeanu","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2025112603023534200_vkaf185-B42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1475-2875-13-386","article-title":"Humanized HLA-DR4.RagKO.IL2R\u03b3cKO.NOD (DRAG) mice sustain the complex vertebrate life cycle of Plasmodium falciparum malaria","volume":"13","author":"Wijayalath","year":"2014","journal-title":"Malar J"},{"key":"2025112603023534200_vkaf185-B43","doi-asserted-by":"crossref","first-page":"1367566","DOI":"10.3389\/fcimb.2024.1367566","article-title":"Reconstitution of human microglia and resident T cells in the brain of humanized DRAGA mice","volume":"14","author":"Ghosh Roy","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"2025112603023534200_vkaf185-B44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/21645515.2017.1403703","article-title":"Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2R\u03b3c KO. NOD)","volume":"14","author":"Mendoza","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2025112603023534200_vkaf185-B45","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/v14091927","article-title":"Comparing current and next-generation humanized mouse models for advancing HIV and HIV\/Mtb co-infection studies","volume":"14","author":"Lepard","year":"2022","journal-title":"Viruses"},{"key":"2025112603023534200_vkaf185-B46","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3389\/fimmu.2018.00816","article-title":"Dissemination of Orientia tsutsugamushi, a causative agent of scrub typhus, and immunological responses in the humanized DRAGA mouse","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Immunol"},{"key":"2025112603023534200_vkaf185-B47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1126\/science.3014648","article-title":"The role of mononuclear phagocytes in HTLV-III\/LAV infection","volume":"233","author":"Gartner","year":"1986","journal-title":"Science"},{"key":"2025112603023534200_vkaf185-B48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00002030-199707000-00003","article-title":"Germinal centre CD4+ T cells are an important site of HIV replication in vivo","volume":"11","author":"Hufert","year":"1997","journal-title":"AIDS"},{"key":"2025112603023534200_vkaf185-B49","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.187.6.949","article-title":"The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy","volume":"187","author":"Tenner-Racz","year":"1998","journal-title":"J Exp Med"},{"key":"2025112603023534200_vkaf185-B50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/aid.2005.21.363","article-title":"Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms","volume":"21","author":"Folkvord","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025112603023534200_vkaf185-B51","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.4049\/jimmunol.178.11.6975","article-title":"CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue","volume":"178","author":"Connick","year":"2007","journal-title":"J Immunol"},{"key":"2025112603023534200_vkaf185-B52","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1038\/ncomms9608","article-title":"Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection","volume":"6","author":"Miles","year":"2015","journal-title":"Nat Commun"},{"key":"2025112603023534200_vkaf185-B53","year":"2022"},{"key":"2025112603023534200_vkaf185-B54","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1038\/srep10443","article-title":"TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1","volume":"5","author":"Allam","year":"2015","journal-title":"Sci Rep"},{"key":"2025112603023534200_vkaf185-B55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2019.09.007","article-title":"Rapid transduction and expansion of transduced T cells with maintenance of central memory populations","volume":"16","author":"Pampusch","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2025112603023534200_vkaf185-B56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"Klein","year":"2012","journal-title":"Nature"},{"key":"2025112603023534200_vkaf185-B57","doi-asserted-by":"crossref","first-page":"1101446","DOI":"10.3389\/fimmu.2023.1101446","article-title":"Assessment of anti-CD20 antibody pre-treatment for augmentation of CAR-T cell therapy in SIV-infected rhesus macaques","volume":"14","author":"Pampusch","year":"2023","journal-title":"Front Immunol"},{"key":"2025112603023534200_vkaf185-B58","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mt.2015.102","article-title":"HIV-specific immunity derived from chimeric antigen receptor\u2013engineered stem cells","volume":"23","author":"Zhen","year":"2015","journal-title":"Mol Ther"},{"key":"2025112603023534200_vkaf185-B59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13058-021-01391-1","article-title":"Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy","volume":"23","author":"Jiao","year":"2021","journal-title":"Breast Cancer Res"},{"key":"2025112603023534200_vkaf185-B60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/v15010202","article-title":"Development of HIV-resistant CAR T cells by CRISPR\/Cas-mediated CAR integration into the CCR5 locus","volume":"15","author":"Rothemejer","year":"2023","journal-title":"Viruses"},{"key":"2025112603023534200_vkaf185-B61","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ymthe.2020.05.012","article-title":"HIV-resistant and HIV-specific CAR-modified CD4+ T cells mitigate HIV disease progression and confer CD4+ T cell help in vivo","volume":"28","author":"Maldini","year":"2020","journal-title":"Mol Ther"},{"key":"2025112603023534200_vkaf185-B62","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","article-title":"Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo","volume":"28","author":"Holt","year":"2010","journal-title":"Nat Biotechnol"},{"key":"2025112603023534200_vkaf185-B63","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/v2020574","article-title":"CCR5: from natural resistance to a new anti-HIV strategy","volume":"2","author":"Lopalco","year":"2010","journal-title":"Viruses"},{"key":"2025112603023534200_vkaf185-B64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40425-019-0518-z","article-title":"Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts","volume":"7","author":"Capasso","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2025112603023534200_vkaf185-B65","doi-asserted-by":"crossref","first-page":"684016","DOI":"10.3389\/fmicb.2021.684016","article-title":"HIV-1-specific CAR-T cells with cell-intrinsic PD-1 checkpoint blockade enhance anti-HIV efficacy in vivo","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Microbiol"},{"key":"2025112603023534200_vkaf185-B66","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jcyt.2024.03.003","article-title":"CAR-T cell expansion platforms yield distinct T cell differentiation states","volume":"26","author":"Song","year":"2024","journal-title":"Cytotherapy"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/214\/11\/3017\/64038951\/vkaf185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/214\/11\/3017\/64038951\/vkaf185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T08:03:08Z","timestamp":1764144188000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/214\/11\/3017\/8233937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":66,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,8,13]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkaf185","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,8,13]]}}}